Erythropoietin induces tumour progression and CD39 expression on immune cells in a preclinical model of triple‐negative breast cancer. - Bessoles, Stéphanie; Chiron, Andrada; Sarrabayrouse, Guillaume; De La Grange, Pierre; Abina, Amine M.; Hacein‐Bey‐Abina, Salima (Immunology, 2024)